MLYS NASDAQ
Mineralys Therapeutics, Inc.
1W: +10.8%
1M: +4.5%
3M: +8.4%
YTD: -15.3%
1Y: +87.8%
3Y: +93.2%
$29.85
-0.38 (-1.26%)
Weekly Expected Move ±8.2%
$23
$25
$27
$30
$32
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-152M
Net Income
+19.5% YoY
$-136M
Free Cash Flow
+29.2% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-36.2%
ROA-35.0%
ROIC1362.7%
Valuation
P/E-16.3
P/B3.9
EV/EBITDA-9.5
Leverage
Debt/Equity0.00
Current Ratio43.76
Interest Cov.0.0x
Quality Scores
Piotroski F3/9
Altman Z88.46
Beneish M0.00